Zheshang Securities' research report pointed out that the leading chain pharmacies, with their better supply chain management, upstream bargaining power, and continuously improving refined management capabilities, are expected to effectively hedge against the risks of declining gross margin brought about by the increase in the proportion of prescription drugs and price changes, thereby maintaining better profitability. Moreover, the leading pharmacies are expected to attract more customers with their advantages such as low stock price, full product categories, excellent services, and large scale, thus driving rapid growth in revenue and profit, and further promoting the concentration of the industry. Recommended stocks to watch: LBX Pharmacy Chain Joint Stock, Yifeng Pharmacy Chain, and Dashenlin Pharmaceutical Group.